BioVie Inc

Focusing on Finding Solutions for Healthier Brain, Memory, and Movement. Our neurology strategy is centered at what we understand to be the nexus of biochemistry, cellular energetics, and neuroprotection, enabling us to explore the potential of our pipeline molecules to decrease inflammation, enhance glucose utilization, protect neurons, and facilitate energy transfer within the central nervous system, ultimately leading to improvements in memory and movement, and a healthier brain. Our lead Neuroscience molecule (NE3107) is currently being investigated in human clinical studies to assess its hypothesized impact on both Alzheimers and Parkinsons. Exploring the possibilities of improved outcomes, fewer medical burdens,...

Biotech,ascites,liver,liver cirrhosis,cirrhosis,liver disease,alzheimer's,dementia,parkinson's,clinical research,clinical trials,biotechnology,scientific research,cognitive decline,neuroscience,ne3107,and neurodegenerative

Biovie inc operates in the Biotechnology industry.

Biovie inc's revenue is 11m - 100m

Biovie inc has 11 - 50 employees.